Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
18 Dec 2019 Asciminib Shows Activity in Heavily Pretreated Patients with CML Haematologic malignancies - Anticancer agents & Biologic therapy
17 Dec 2019 EMA Recommends Extension of Therapeutic Indications for Apalutamide Genitourinary cancers - Anticancer agents & Biologic therapy
16 Dec 2019 HER2CLIMB and DESTINY-Breast01 Findings in Heavily Pretreated HER2-positive MBC Breast cancer - Anticancer agents & Biologic therapy
13 Dec 2019 The QuIP Study Attempts to Harmonise the Use of TMB Panels Pathology/Molecular biology - Translational research
13 Dec 2019 BL-8040, Pembrolizumab and Chemotherapy Deliver Promising Disease Control in Patients with Metastatic Pancreatic Adenocarcinoma Gastrointestinal cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
13 Dec 2019 Sitravatinib Plus Tislelizumab Show Promise in Platinum-Resistant Advanced Ovarian Cancer Gynaecologic malignancies - Cancer Immunology and Immunotherapy
12 Dec 2019 First-Line Combination Treatment with Durvalumab Plus Platinum and Etoposide Has Manageable Safety in ES-SCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
12 Dec 2019 First-line Nivolumab Plus Ipilimumab is Safe and Provides Encouraging Survival in Patients with Advanced NSCLC and Co-Morbidity or Poor Performance Status Lung and other thoracic tumours - Cancer in Special Situations / Population - Cancer Immunology and Immunotherapy
12 Dec 2019 Pembrolizumab May Be Considered as a First-Line Treatment Option in Non-Squamous NSCLC Even in the Presence of KRAS Mutations Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
12 Dec 2019 Early Introduction of Corticosteroids May Alter the Efficacy of Immune Checkpoint Inhibitors Lung and other thoracic tumours - Genitourinary cancers - Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
12 Dec 2019 First-line Nivolumab Plus Chemotherapy Did Not Meet the Primary Endpoint of Overall Survival in Non-Squamous NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
11 Dec 2019 A Daratumumab-Based Combination Shows a Significant Improvement in Overall Survival in Newly Diagnosed Multiple Myeloma Haematologic malignancies - Anticancer agents & Biologic therapy
09 Dec 2019 FDA Approves Atezolizumab With Nab-paclitaxel and Carboplatin for Metastatic Non-squamous NSCLC Without EGFR/ALK Aberrations Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
06 Dec 2019 Cervical Cancer Ranked in the Top Three Cancers Affecting Women Younger Than 45 Years Gynaecologic malignancies - Epidemiology/Etiology/Cancer Prevention
05 Dec 2019 FDA Approves Crizanlizumab-tmca and Voxelotor for Sickle Cell Disease Haematologic malignancies